IL-2	B-protein
-mediated	O
cell	O
cycle	O
progression	O
and	O
inhibition	O
of	O
apoptosis	O
does	O
not	O
require	O
NF-kappa	B-protein
B	I-protein
or	O
activating	O
protein-1	O
activation	O
in	O
primary	O
human	O
T	O
cells	O
.	O

The	O
IL-2	B-protein
growth	O
hormone	O
is	O
the	O
major	O
growth	O
factor	O
of	O
activated	O
T	B-cell_type
lymphocytes	I-cell_type
during	O
a	O
developing	O
immune	O
response	O
.	O

IL-2	B-protein
is	O
required	O
not	O
only	O
for	O
cell	O
cycle	O
progression	O
but	O
also	O
to	O
protect	O
Ag-activated	B-cell_type
T	I-cell_type
cells	I-cell_type
from	O
programmed	O
cell	O
death	O
.	O

In	O
several	O
cell	O
types	O
,	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
and/or	O
activating	B-protein
protein-1	I-protein
(	O
AP-1	B-protein
)	O
has	O
been	O
demonstrated	O
to	O
be	O
extremely	O
important	O
in	O
blocking	O
apoptosis	O
.	O

To	O
determine	O
whether	O
either	O
or	O
both	O
of	O
these	O
transcription	B-protein
factors	I-protein
are	O
involved	O
in	O
cell	O
survival	O
or	O
cell	O
cycle	O
progression	O
in	O
response	O
to	O
IL-2	B-protein
,	O
primary	B-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
responsive	O
to	O
the	O
growth	O
factor	O
were	O
analyzed	O
for	O
NF-kappa	O
B	O
and	O
AP-1	O
activation	O
.	O

The	O
current	O
study	O
clearly	O
demonstrates	O
that	O
IL-2	B-protein
does	O
not	O
induce	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	O
degradation	O
or	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
primary	B-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
that	O
respond	O
to	O
IL-2	B-protein
by	O
entering	O
the	O
cell	O
cycle	O
and	O
avoiding	O
apoptosis	O
.	O

Similarly	O
,	O
IL-2	B-protein
neither	O
activates	O
JNK	B-protein
nor	O
increases	O
AP-1	B-protein
binding	O
activity	O
to	O
a	O
consensus	O
o-tetradecanoylphorbol	B-DNA
13-acetate	I-DNA
(	I-DNA
TPA	I-DNA
)	I-DNA
response	I-DNA
element	I-DNA
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
growth	B-protein
factor	I-protein
does	O
induce	O
the	O
activation	O
of	O
STAT3	B-protein
and	O
STAT5	B-protein
in	O
these	O
cells	O
,	O
as	O
has	O
been	O
previously	O
demonstrated	O
.	O

These	O
data	O
show	O
that	O
neither	O
NF-kappa	B-protein
B	I-protein
nor	O
AP-1	B-protein
activation	O
is	O
required	O
for	O
IL-2	B-protein
-mediated	O
survival	O
or	O
cell	O
cycle	O
progression	O
in	O
activated	O
primary	B-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Cha	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
meJournal	NULL
of	NULL
IL-2-Mediated	NULL
Cell	NULL
Cycle	NULL
Progression	NULL
and	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
Inhibition	NULL
of	NULL
Apoptosis	NULL
Does	NULL
Not	NULL
Require	NULL
NF-	NULL
xB	NULL
or	NULL
Activating	NULL
Protein-1	NULL
Activation	NULL
in	NULL
Primary	NULL
Human	NULL
T	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Milena	NULL
Iacobelli	NULL
,	NULL
Forest	NULL
Rohwer	NULL
,	NULL
Paul	NULL
Shanahan	NULL
,	NULL
Jose	NULL
A.	NULL
Quiroz	NULL
and	NULL
Kathleen	NULL
L.	NULL
McGuire	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:3308-3315	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3308	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
60	NULL
articles	NULL
,	NULL
24	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3308	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
IL-2-Mediated	NULL
Cell	NULL
Cycle	NULL
Progression	NULL
and	NULL
Inhibition	NULL
of	NULL
Apoptosis	NULL
Does	NULL
Not	NULL
Require	NULL
NF-B	NULL
or	NULL
Activating	NULL
Protein-1	NULL
Activation	NULL
in	NULL
Primary	NULL
Human	NULL
T	NULL
Cells	NULL
!	NULL

Milena	NULL
Iacobelli	NULL
,	NULL
*	NULL
Forest	NULL
Rohwer	NULL
,	NULL
``	NULL
Paul	NULL
Shanahan	NULL
,	NULL
Jose	NULL
A.	NULL
Quiroz	NULL
,	NULL
and	NULL
Kathleen	NULL
L.	NULL
McGuire	NULL
``	NULL
The	NULL
IL-2	NULL
growth	NULL
hormone	NULL
is	NULL
the	NULL
major	NULL
growth	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
during	NULL
a	NULL
developing	NULL
immune	NULL
response	NULL
.	NULL

IL-2	NULL
is	NULL
required	NULL
not	NULL
only	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
but	NULL
also	NULL
to	NULL
protect	NULL
Ag-activated	NULL
T	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

In	NULL
several	NULL
cell	NULL
types	NULL
,	NULL
activation	NULL
of	NULL
and/or	NULL
activating	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
extremely	NULL
important	NULL
in	NULL
blocking	NULL
apoptosis	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
either	NULL
or	NULL
both	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
cell	NULL
survival	NULL
or	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
,	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
responsive	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
were	NULL
analyzed	NULL
for	NULL
NF-B	NULL
and	NULL
AP-1	NULL
activation	NULL
.	NULL

The	NULL
current	NULL
study	NULL
clearly	NULL
demonstrates	NULL
that	NULL
IL-2	NULL
does	NULL
not	NULL
induce	NULL
IxBa	NULL
degradation	NULL
or	NULL
NF-xB	NULL
activation	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
that	NULL
respond	NULL
to	NULL
IL-2	NULL
by	NULL
entering	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
avoiding	NULL
apoptosis	NULL
.	NULL

Similarly	NULL
,	NULL
IL-2	NULL
neither	NULL
activates	NULL
JNK	NULL
nor	NULL
increases	NULL
AP-1	NULL
binding	NULL
activity	NULL
to	NULL
a	NULL
consensus	NULL
o-tetradecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
response	NULL
element	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
growth	NULL
factor	NULL
does	NULL
induce	NULL
the	NULL
activation	NULL
of	NULL
STAT3	NULL
and	NULL
STATS	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
neither	NULL
NF-xB	NULL
nor	NULL
AP-1	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
IL-2-mediated	NULL
survival	NULL
or	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
activated	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
3308-3315.	NULL
he	NULL
IL-2	NULL
growth	NULL
factor	NULL
is	NULL
produced	NULL
upon	NULL
antigenic	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
vital	NULL
to	NULL
the	NULL
cellular	NULL
expansion	NULL
required	NULL
for	NULL
a	NULL
productive	NULL
immune	NULL
response	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

While	NULL
a	NULL
lack	NULL
of	NULL
IL-2	NULL
production	NULL
results	NULL
in	NULL
the	NULL
development	NULL
of	NULL
an	NULL
unresponsive	NULL
state	NULL
in	NULL
Ag-stimulated	NULL
T	NULL
cells	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

4	NULL
)	NULL
,	NULL
IL-2	NULL
stimulation	NULL
both	NULL
induces	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
inhibits	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
been	NULL
performed	NULL
to	NULL
delineate	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
later	NULL
events	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
biological	NULL
consequences	NULL
of	NULL
IL-2	NULL
stimulation	NULL
on	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
relief	NULL
from	NULL
apoptosis	NULL
,	NULL
but	NULL
these	NULL
events	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
are	NULL
still	NULL
incompletely	NULL
understood	NULL
.	NULL

It	NULL
has	NULL
been	NULL
clearly	NULL
demonstrated	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
protect	NULL
several	NULL
cell	NULL
types	NULL
from	NULL
apoptotic	NULL
death	NULL
in	NULL
response	NULL
to	NULL
various	NULL
signals	NULL
(	NULL
Refs	NULL
.	NULL

5-9	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
like	NULL
other	NULL
growth	NULL
factors	NULL
,	NULL
inhibits	NULL
apoptosis	NULL
(	NULL
Ref	NULL
.	NULL

12	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

13	NULL
)	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
NF-KB	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
logical	NULL
to	NULL
propose	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
death	NULL
by	NULL
IL-2	NULL
is	NULL
mediated	NULL
by	NULL
NF-KB	NULL
but	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
this	NULL
mechanism	NULL
protects	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
death	NULL
that	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

Department	NULL
of	NULL
Biology	NULL
and	NULL
Molecular	NULL
Biology	NULL
Institute	NULL
,	NULL
San	NULL
Diego	NULL
State	NULL
University	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92182	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
16	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Cancer	NULL
Institute	NULL
Grant	NULL
CA53382	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health/Minority	NULL
Biomedical	NULL
Research	NULL
Support	NULL
Grant	NULL
GM45765	NULL
(	NULL
to	NULL
KL.M	NULL
.	NULL
)	NULL

and	NULL
an	NULL
Achievement	NULL
Rewards	NULL
for	NULL
College	NULL
Scientists	NULL
scholarship	NULL
(	NULL
to	NULL
F.R	NULL
.	NULL
)	NULL

.	NULL

*	NULL
These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL

3	NULL
Current	NULL
address	NULL
:	NULL
Scripps	NULL
Institute	NULL
of	NULL
Oceanography	NULL
,	NULL
8604	NULL
La	NULL
Jolla	NULL
Shores	NULL
Dr.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
.	NULL

*Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Kathlen	NULL
L.	NULL
McGuire	NULL
,	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
San	NULL
Diego	NULL
State	NULL
University	NULL
,	NULL
5500	NULL
Campanile	NULL
Dr.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
92182-4614	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
kmcguire	NULL
@	NULL
sunstroke.sdsu.edu	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
AP-1	NULL
``	NULL
transcription	NULL
factor	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
protect	NULL
cells	NULL
from	NULL
apoptotic	NULL
death	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
Jun	NULL
N-terminal	NULL
kinases	NULL
,	NULL
JNK1/2	NULL
,	NULL
and	NULL
AP-1	NULL
activity	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
many	NULL
circumstances	NULL
(	NULL
Refs	NULL
.	NULL

18-22	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

23	NULL
and	NULL
24	NULL
)	NULL
.	NULL

Both	NULL
AP-1	NULL
binding	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
and	NULL
JNK	NULL
activation	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
IL-2	NULL
stimulation	NULL
in	NULL
responsive	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
activation	NULL
of	NULL
AP-1	NULL
or	NULL
JNK	NULL
correlates	NULL
with	NULL
either	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
IL-2-deprived	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
or	NULL
,	NULL
conversely	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
IL-2-stimulated	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
current	NULL
study	NULL
was	NULL
conducted	NULL
to	NULL
determine	NULL
whether	NULL
NF-KB	NULL
and/or	NULL
AP-1	NULL
activation	NULL
is	NULL
correlated	NULL
with	NULL
cell	NULL
cycle	NULL
progression	NULL
or	NULL
survival	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
.	NULL

As	NULL
demonstrated	NULL
here	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
is	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
the	NULL
primary	NULL
human	NULL
T	NULL
cell	NULL
populations	NULL
analyzed	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
STAT	NULL
proteins	NULL
,	NULL
previously	NULL
demonstrated	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
responsive	NULL
T	NULL
cells	NULL
(	NULL
28-33	NULL
)	NULL
,	NULL
are	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
neither	NULL
AP-1	NULL
nor	NULL
NF-KB	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
cell	NULL
cycle	NULL
progression	NULL
or	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
observed	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
Thymic	NULL
blast	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
thymocytes	NULL
were	NULL
isolated	NULL
from	NULL
human	NULL
tissue	NULL
by	NULL
mincing	NULL
and	NULL
passage	NULL
over	NULL
a	NULL
Ficoll	NULL
gradient	NULL
.	NULL

The	NULL
isolated	NULL
thymocytes	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
5	NULL
ug/tal	NULL
PHA	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
10	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
After	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
-glutamate	NULL
,	NULL
and	NULL
antibi-otics	NULL
)	NULL
with	NULL
10	NULL
U/ml	NULL
IL-2	NULL
(	NULL
Chiron	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
fed	NULL
each	NULL
day	NULL
for	NULL
3-6	NULL
days	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
thymic	NULL
blast	NULL
cells	NULL
(	NULL
TBCs	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
by	NULL
washing	NULL
twice	NULL
and	NULL
culturing	NULL
in	NULL
complete	NULL
medium	NULL
without	NULL
IL-2	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
restimulated	NULL
for	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activating	NULL
protein-1	NULL
;	NULL
JNK	NULL
,	NULL
Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
TBC	NULL
,	NULL
thymic	NULL
blast	NULL
cell	NULL
;	NULL
PB	NULL
,	NULL
peripheral	NULL
blood	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
TPA	NULL
,	NULL
o-tetradecanoylphorbol	NULL
13-acetate	NULL
;	NULL
TRE	NULL
,	NULL
TPA	NULL
response	NULL
element	NULL
;	NULL
TUNEL	NULL
,	NULL
terminal	NULL
deoxynucleotidyltransferase-mediated	NULL
dUTP	NULL
nick	NULL
end	NULL
labeling	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
100	NULL
U/ml	NULL
IL-2	NULL
,	NULL
10	NULL
ng/ml	NULL
PMA	NULL
,	NULL
1.5	NULL
M	NULL
ionomycin	NULL
,	NULL
and/or	NULL
25	NULL
ng/ml	NULL
anisomycin	NULL
.	NULL

All	NULL
TBC	NULL
preparations	NULL
were	NULL
checked	NULL
for	NULL
responses	NULL
to	NULL
IL-2	NULL
using	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
uptake	NULL
,	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
or	NULL
STAT3	NULL
phosphorylation	NULL
analysis	NULL
.	NULL

PBMC	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
cultured	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
for	NULL
48	NULL
h	NULL
,	NULL
grown	NULL
in	NULL
IL-2	NULL
for	NULL
4	NULL
days	NULL
,	NULL
and	NULL
then	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
approximately	NULL
44	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
restimulation	NULL
for	NULL
4	NULL
h	NULL
with	NULL
100	NULL
U/ml	NULL
IL-2	NULL
,	NULL
10	NULL
ng/ml	NULL
PMA	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
1.5	NULL
uM	NULL
ionomycin	NULL
.	NULL

The	NULL
response	NULL
of	NULL
this	NULL
population	NULL
to	NULL
IL-2	NULL
was	NULL
verified	NULL
by	NULL
cell	NULL
cycle	NULL
analysis	NULL
using	NULL
propidium	NULL
iodine	NULL
staining	NULL
as	NULL
described	NULL
below	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
staining	NULL
revealed	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
97	NULL
%	NULL
T	NULL
cells	NULL
(	NULL
CD3+*	NULL
)	NULL
and	NULL
approximately	NULL
50	NULL
%	NULL
CD4*	NULL
and	NULL
50	NULL
%	NULL
CD8	NULL
*	NULL
,	NULL
and	NULL
essentially	NULL
100	NULL
%	NULL
expressed	NULL
the	NULL
IL-2R	NULL
ae-chain	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
referred	NULL
to	NULL
in	NULL
the	NULL
text	NULL
as	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
TBCs	NULL
analyzed	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
32	NULL
h	NULL
or	NULL
for	NULL
8	NULL
h	NULL
followed	NULL
by	NULL
a	NULL
24-h	NULL
restimulation	NULL
with	NULL
100	NULL
U/ml	NULL
IL-2	NULL
.	NULL

PB	NULL
T	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
44	NULL
h	NULL
or	NULL
for	NULL
16	NULL
h	NULL
followed	NULL
by	NULL
a	NULL
28-h	NULL
restimulation	NULL
with	NULL
IL-2	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
fixed	NULL
by	NULL
resuspension	NULL
in	NULL
PBS/ethanol	NULL
(	NULL
1/1	NULL
)	NULL
.	NULL

Before	NULL
analysis	NULL
,	NULL
the	NULL
fixed	NULL
cells	NULL
were	NULL
resuspended	NULL
into	NULL
100	NULL
pg/ml	NULL
RNase	NULL
A	NULL
in	NULL
PBS	NULL
and	NULL
incubated	NULL
for	NULL
30-60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Propidium	NULL
iodine	NULL
(	NULL
50	NULL
pg/ml	NULL
!	NULL
)	NULL

was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
FACS	NULL
data	NULL
was	NULL
performed	NULL
using	NULL
WINMIDLI	NULL
,	NULL
version	NULL
2.1.4	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
GyG	NULL
;	NULL
,	NULL
S	NULL
,	NULL
or	NULL
G	NULL
,	NULL
+M	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
MultiCycle	NULL
AV	NULL
program	NULL
from	NULL
Phoenix	NULL
Flow	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

TUNEL	NULL
assay	NULL
TBCs	NULL
analyzed	NULL
for	NULL
apoptosis	NULL
using	NULL
the	NULL
TUNEL	NULL
technique	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
32	NULL
h	NULL
or	NULL
for	NULL
8	NULL
h	NULL
followed	NULL
by	NULL
a	NULL
24-h	NULL
restimulation	NULL
with	NULL
IL-2	NULL
or	NULL
PMA	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
into	NULL
polystyrene	NULL
tubes	NULL
(	NULL
previously	NULL
precoated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
and	NULL
BSA	NULL
in	NULL
PBS	NULL
)	NULL
and	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
para-formaldehyde	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Before	NULL
FACS	NULL
analysis	NULL
,	NULL
samples	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
into	NULL
elongation	NULL
buffer	NULL
(	NULL
1X	NULL
TdT	NULL
buffer	NULL
,	NULL
2.5	NULL
mM	NULL
CoCl	NULL
;	NULL
,	NULL
5	NULL
uM	NULL
biotin-16-dUTP	NULL
,	NULL
and	NULL
10	NULL
U	NULL
TdT	NULL
;	NULL
Boehringer	NULL
Mann-heim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
elongation	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
into	NULL
staining	NULL
solution	NULL
(	NULL
5	NULL
X	NULL
SSC	NULL
,	NULL
5	NULL
%	NULL
milk	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
a	NULL
1/2000	NULL
dilution	NULL
of	NULL
FITC-avidin	NULL
(	NULL
Sigma	NULL
)	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
staining	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
0.5	NULL
%	NULL
formaldehyde/PBS	NULL
before	NULL
analysis	NULL
by	NULL
FACS	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Cells	NULL
treated	NULL
as	NULL
indicated	NULL
(	NULL
~5	NULL
X	NULL
10	NULL
``	NULL
/condition	NULL
)	NULL
were	NULL
harvested	NULL
into	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
%	NULL
sodium	NULL
de-oxycholate	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
containing	NULL
phosphatase	NULL
and	NULL
protease	NULL
inhibitors	NULL
(	NULL
NaF	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
at	NULL
25	NULL
pg/ml	NULL
;	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
leupeptin	NULL
,	NULL
aprotonin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
at	NULL
2	NULL
ug/ml	NULL
;	NULL
and	NULL
PMSF	NULL
at	NULL
1	NULL
mM	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
system	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitro-cellulose	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Equal	NULL
loading	NULL
was	NULL
confirmed	NULL
by	NULL
Pon-ceau	NULL
S	NULL
staining	NULL
of	NULL
the	NULL
filter	NULL
after	NULL
transfer	NULL
.	NULL

Antisera	NULL
recognizing	NULL
I	NULL
«	NULL
B-a	NULL
(	NULL
C-15	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
phosphorylated	NULL
and	NULL
total	NULL
JNK1/2	NULL
(	NULL
PhosphoPlus	NULL
SAPK/JNK	NULL
(	NULL
Thr'®/Tyr'*	NULL
``	NULL
)	NULL
Ab	NULL
Kit	NULL
,	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverley	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
phosphorylated	NULL
and	NULL
total	NULL
STAT3	NULL
(	NULL
PhosphoPlus	NULL
Stat3	NULL
(	NULL
Tyr	NULL
'	NULL
``	NULL
``	NULL
)	NULL
Ab	NULL
Kit	NULL
,	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
,	NULL
and	NULL
phosphorylated	NULL
(	NULL
phos-pho-specific	NULL
STATSA	NULL
(	NULL
Tyr	NULL
``	NULL
)	NULL
,	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
and	NULL
total	NULL
(	NULL
Trans-duction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
STATS	NULL
were	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
using	NULL
horseradish	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
antisera	NULL
(	NULL
or	NULL
anti-mouse	NULL
antisera	NULL
for	NULL
total	NULL
STATS	NULL
)	NULL
and	NULL
chemiluminescence	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

Stripping	NULL
of	NULL
blots	NULL
for	NULL
reprobing	NULL
was	NULL
performed	NULL
in	NULL
62.5	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
6.7	NULL
)	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
100	NULL
mM	NULL
2-ME	NULL
for	NULL
30	NULL
min	NULL
at	NULL
65°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
above	NULL
.	NULL

EMSAs	NULL
were	NULL
also	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5-10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
0.5-2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Similarly	NULL
,	NULL
if	NULL
applicable	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
antiserum	NULL
specific	NULL
for	NULL
Re/NF-	NULL
«	NULL
B	NULL
(	NULL
0.6	NULL
ug	NULL
for	NULL
Bcl-3	NULL
)	NULL
or	NULL
AP-1	NULL
family	NULL
3309	NULL
member	NULL
proteins	NULL
was	NULL
added	NULL
during	NULL
this	NULL
preincubation	NULL
step	NULL
.	NULL

Antisera	NULL
for	NULL
p50	NULL
(	NULL
no	NULL
.	NULL

1141	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
no	NULL
.	NULL

1207	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
no	NULL
.	NULL

1136	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Nancy	NULL
Rice	NULL
,	NULL
and	NULL
Bel-3-	NULL
and	NULL
c-Fos-specific	NULL
antisera	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

°°P-labeled	NULL
consensus	NULL
TRE	NULL
,	NULL
NF-KB	NULL
,	NULL
or	NULL
Oct	NULL
probe	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
then	NULL
electro-phoresed	NULL
through	NULL
6.5	NULL
%	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
4	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
native	NULL
acrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
running	NULL
buffer	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
XARS5	NULL
film	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
probes	NULL
used	NULL
in	NULL
this	NULL
analysis	NULL
were	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
5'-gatecCAACGGCAGGGGAATCTCCCTCTCCTT	NULL
;	NULL
TRE	NULL
,	NULL
5'-gatc-CGGCTGACTCATCA	NULL
;	NULL
and	NULL
Oct	NULL
,	NULL
5'-gatecTGTCGAATGCAAATCACTA	NULL
GAA	NULL
.	NULL

Results	NULL
Growth	NULL
factors	NULL
are	NULL
known	NULL
to	NULL
induce	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
appropriate	NULL
receptors	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
these	NULL
biological	NULL
responses	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
,	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
thymus	NULL
tissue	NULL
obtained	NULL
from	NULL
patients	NULL
undergoing	NULL
corrective	NULL
cardiac	NULL
surgery	NULL
at	NULL
Children	NULL
's	NULL
Hospital	NULL
in	NULL
San	NULL
Diego	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
to	NULL
express	NULL
the	NULL
high	NULL
affinity	NULL
IL-2R	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
IL-2-containing	NULL
medium	NULL
for	NULL
several	NULL
days	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
population	NULL
of	NULL
blast	NULL
cells	NULL
called	NULL
TBCs	NULL
.	NULL

The	NULL
phenotype	NULL
and	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
TBCs	NULL
have	NULL
previously	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
CD3	NULL
,	NULL
approximately	NULL
two-thirds	NULL
of	NULL
the	NULL
cells	NULL
are	NULL
single	NULL
positive	NULL
for	NULL
CD4	NULL
or	NULL
CD8	NULL
,	NULL
one-third	NULL
of	NULL
the	NULL
cells	NULL
are	NULL
double	NULL
positive	NULL
for	NULL
both	NULL
markers	NULL
,	NULL
and	NULL
all	NULL
cells	NULL
express	NULL
the	NULL
IL-2R	NULL
«	NULL
-chain	NULL
.	NULL

The	NULL
high	NULL
TCR/CD3	NULL
expression	NULL
levels	NULL
and	NULL
the	NULL
response	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
IL-2	NULL
strongly	NULL
suggest	NULL
that	NULL
they	NULL
represent	NULL
the	NULL
more	NULL
mature	NULL
cells	NULL
found	NULL
in	NULL
the	NULL
thymus	NULL
rather	NULL
than	NULL
immature	NULL
or	NULL
developing	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
usually	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
.	NULL

Culturing	NULL
the	NULL
cells	NULL
in	NULL
this	NULL
manner	NULL
allows	NULL
for	NULL
IL-2-dependent	NULL
events	NULL
to	NULL
be	NULL
studied	NULL
independently	NULL
of	NULL
activation	NULL
events	NULL
that	NULL
occur	NULL
via	NULL
the	NULL
TCR	NULL
.	NULL

The	NULL
advantage	NULL
of	NULL
TBCs	NULL
over	NULL
PB	NULL
T	NULL
cells	NULL
is	NULL
that	NULL
large	NULL
numbers	NULL
of	NULL
cells	NULL
can	NULL
be	NULL
obtained	NULL
from	NULL
a	NULL
single	NULL
thymus	NULL
to	NULL
study	NULL
both	NULL
cellular	NULL
and	NULL
molecular	NULL
events	NULL
in	NULL
a	NULL
single	NULL
population	NULL
.	NULL

Upon	NULL
IL-2	NULL
withdrawal	NULL
,	NULL
about	NULL
90	NULL
%	NULL
of	NULL
TBCs	NULL
synchronize	NULL
in	NULL
the	NULL
G	NULL
,	NULL
/G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
within	NULL
32	NULL
h	NULL
,	NULL
and	NULL
an	NULL
average	NULL
of	NULL
22	NULL
%	NULL
are	NULL
apoptotic	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
,	NULL
only	NULL
about	NULL
65	NULL
%	NULL
of	NULL
TBCs	NULL
are	NULL
in	NULL
G	NULL
,	NULL
,	NULL
with	NULL
30	NULL
%	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
and	NULL
only	NULL
11	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
on	NULL
the	NULL
average	NULL
,	NULL
are	NULL
apoptotic	NULL
.	NULL

As	NULL
indicated	NULL
above	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
normally	NULL
accomplished	NULL
by	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
holds	NULL
in	NULL
the	NULL
cytoplasm	NULL
the	NULL
p50/ReIA	NULL
heterodimers	NULL
that	NULL
make	NULL
up	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

36-38	NULL
)	NULL
.	NULL

Upon	NULL
degradation	NULL
of	NULL
NF-KB	NULL
is	NULL
rapidly	NULL
transported	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
is	NULL
transcriptionally	NULL
active	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-2	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
TBCs	NULL
,	NULL
the	NULL
fate	NULL
of	NULL
IxBa	NULL
was	NULL
analyzed	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-2	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
no	NULL
significant	NULL
degradation	NULL
of	NULL
IxBa	NULL
was	NULL
detected	NULL
with	NULL
IL-2	NULL
stimulation	NULL
at	NULL
any	NULL
time	NULL
point	NULL
ana-lyzed	NULL
,	NULL
even	NULL
several	NULL
hours	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PMA	NULL
induced	NULL
a	NULL
significant	NULL
and	NULL
sustained	NULL
(	NULL
up	NULL
to	NULL
4	NULL
h	NULL
)	NULL
degradation	NULL
of	NULL
IxBa	NULL
at	NULL
concentrations	NULL
well	NULL
within	NULL
those	NULL
used	NULL
normally	NULL
in	NULL
experimentation	NULL
on	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

IkB-a	NULL
is	NULL
only	NULL
one	NULL
of	NULL
several	NULL
IB	NULL
proteins	NULL
(	NULL
36-38	NULL
)	NULL
,	NULL
and	NULL
mechanisms	NULL
other	NULL
than	NULL
IxB	NULL
degradation	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IkB-a	NULL
leads	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
release	NULL
without	NULL
degradation	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
39	NULL
)	NULL
.	NULL

To	NULL
definitively	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
present	NULL
in	NULL
nuclei	NULL
of	NULL
TBCs	NULL
stimulated	NULL
with	NULL
IL-2	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
analyzed	NULL
.	NULL

TBCs	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
to	NULL
synchronize	NULL
them	NULL
and	NULL
stimulated	NULL
with	NULL
IL-2	NULL
or	NULL
PMA	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
then	NULL
isolated	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
accessed	NULL
by	NULL
EMSA	NULL
analysis	NULL
using	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3310	NULL
LACK	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
AP-1	NULL
ACTIVATION	NULL
BY	NULL
IL-2	NULL
CELL	NULL
CYCLE	NULL
APOPTOSIS	NULL
o	NULL
480	NULL
&	NULL
6	NULL
Go/G1	NULL
90.3+/-4.6	NULL
%	NULL
|	NULL
~	NULL
P	NULL
4000	NULL
|	NULL
s	NULL
se-m-aee	NULL
|g|	NULL
22	NULL
.	NULL

4+/-13	NULL
%	NULL
|	NULL
Ga+M	NULL
-	NULL
2.9+/-1.8	NULL
%	NULL
|	NULL
®	NULL
sacal	NULL
E	NULL
I	NULL
L	NULL
-	NULL
2	NULL
{	NULL
S	NULL
)	NULL
DEPRIVED	NULL
|	NULL
:	NULL
.04	NULL
|	NULL
©	NULL
I	NULL
o	NULL
i	NULL
&	NULL
4	NULL
1600	NULL
)	NULL
’	NULL
!	NULL

<	NULL
|	NULL
o	NULL
a	NULL
sac	NULL
!	NULL

ﬂ	NULL
8-Ke	NULL
!	NULL
'	NULL

,	NULL
If	NULL
“	NULL
€	NULL
)	NULL
-A	NULL
o	NULL
(	NULL
hi	NULL
=	NULL
g	NULL
__	NULL
|	NULL
aso	NULL
-	NULL
67	NULL
S|	NULL
so00	NULL
Go/G1	NULL
64.9+/-6.0	NULL
%	NULL
10.6+/-5.8	NULL
%	NULL
s	NULL
30.4+/-4.4	NULL
%	NULL
|§	NULL
]	NULL
a	NULL
Gaim	NULL
-	NULL
a8+r2.3	NULL
%	NULL
|*	NULL
o	NULL
6	NULL
2000	NULL
;	NULL
©	NULL
IL-2	NULL
RESTIMULATED|	NULL
**	NULL
``	NULL
g-1000	NULL
!	NULL

o	NULL
61	NULL
Bu	NULL
sl	NULL
T	NULL
T	NULL
fluorescence	NULL
FIGURE	NULL
1	NULL
.	NULL

IL-2	NULL
induces	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
TBCs	NULL
.	NULL

TBCs	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
and	NULL
analyzed	NULL
for	NULL
DNA	NULL
content	NULL
using	NULL
propidium	NULL
iodide	NULL
(	NULL
Zef	NULL
?	NULL
)	NULL

and	NULL
apoptosis	NULL
using	NULL
TUNEL	NULL
(	NULL
righ	NULL
?	NULL
)	NULL

.	NULL

The	NULL
graphs	NULL
shown	NULL
are	NULL
representative	NULL
examples	NULL
,	NULL
and	NULL
the	NULL
numbers	NULL
given	NULL
are	NULL
the	NULL
average	NULL
of	NULL
10	NULL
independent	NULL
experiments	NULL
with	NULL
SDs	NULL
indicated	NULL
.	NULL

The	NULL
rather	NULL
large	NULL
SDs	NULL
obtained	NULL
in	NULL
the	NULL
TUNEL	NULL
assay	NULL
are	NULL
indicative	NULL
of	NULL
a	NULL
variability	NULL
between	NULL
TBC	NULL
preparations	NULL
in	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
entering	NULL
apoptosis	NULL
32	NULL
h	NULL
after	NULL
deprivation	NULL
and	NULL
not	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
IL-2	NULL
to	NULL
induce	NULL
cell	NULL
survival	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
IL-2	NULL
routinely	NULL
(	NULL
10/10	NULL
experiments	NULL
)	NULL
reduces	NULL
the	NULL
level	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
observed	NULL
.	NULL

consensus	NULL
NF-KB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
-chain	NULL
pro-moter	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
TBCs	NULL
deprived	NULL
of	NULL
IL-2	NULL
contained	NULL
NF-KB	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
consisted	NULL
of	NULL
p50	NULL
homodimers	NULL
,	NULL
but	NULL
little	NULL
RelA	NULL
or	NULL
c-Rel	NULL
binding	NULL
was	NULL
observed	NULL
.	NULL

IL-2	NULL
stimulation	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
new	NULL
complex	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
appreciably	NULL
increase	NULL
RelA	NULL
or	NULL
c-Rel	NULL
binding	NULL
to	NULL
this	NULL
sequence	NULL
over	NULL
that	NULL
observed	NULL
in	NULL
deprived	NULL
cells	NULL
.	NULL

Because	NULL
a	NULL
significant	NULL
level	NULL
of	NULL
p50	NULL
homodimer	NULL
binding	NULL
was	NULL
evident	NULL
in	NULL
both	NULL
IL-2-deprived	NULL
and	NULL
restimulated	NULL
cells	NULL
,	NULL
IL-2	NULL
(	NULL
min	NULL
)	NULL
0	NULL
5	NULL
15	NULL
30	NULL
«	NULL
ipr	NULL
Te	NULL
``	NULL
IL-2	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
1	NULL
2	NULL
40	NULL
08	NULL
24	NULL
PMA	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

0	NULL
5	NULL
10	NULL
xz	NULL
-_	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
IxB-a	NULL
is	NULL
not	NULL
degraded	NULL
in	NULL
IL-2-stimulated	NULL
TBCs	NULL
.	NULL

TBCs	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
and	NULL
restimulated	NULL
with	NULL
IL-2	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
or	NULL
with	NULL
PMA	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
total	NULL
protein	NULL
was	NULL
analyzed	NULL
for	NULL
IxB-a	NULL
levels	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
TBC	NULL
preparations	NULL
.	NULL

we	NULL
also	NULL
analyzed	NULL
these	NULL
complexes	NULL
for	NULL
increases	NULL
in	NULL
Bel-3	NULL
binding	NULL
.	NULL

While	NULL
Bcel-3	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
interact	NULL
with	NULL
and	NULL
enhance	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
p50	NULL
homodimers	NULL
(	NULL
40-42	NULL
)	NULL
,	NULL
no	NULL
Bel-3	NULL
binding	NULL
was	NULL
detected	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
using	NULL
this	NULL
assay	NULL
.	NULL

PMA	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
decreased	NULL
p50	NULL
homodimer	NULL
formation	NULL
and	NULL
increased	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
containing	NULL
p50	NULL
and	NULL
RelA	NULL
or	NULL
c-Rel	NULL
.	NULL

The	NULL
PMA	NULL
data	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
TBCs	NULL
.	NULL

Fig	NULL
.	NULL

3B	NULL
demonstrates	NULL
that	NULL
NF-KB	NULL
(	NULL
RelA	NULL
or	NULL
c-Rel	NULL
)	NULL
binding	NULL
is	NULL
not	NULL
increased	NULL
in	NULL
TBCs	NULL
stimulated	NULL
from	NULL
30	NULL
min	NULL
to	NULL
24	NULL
h	NULL
with	NULL
IL-2	NULL
.	NULL

Collectively	NULL
,	NULL
the	NULL
data	NULL
demonstrate	NULL
that	NULL
IL-2	NULL
does	NULL
not	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
cells	NULL
that	NULL
respond	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
by	NULL
progressing	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
avoiding	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
does	NULL
not	NULL
play	NULL
a	NULL
role	NULL
in	NULL
these	NULL
biological	NULL
consequences	NULL
of	NULL
IL-2	NULL
stimulation	NULL
in	NULL
TBCs	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
NF-KB	NULL
is	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
freshly	NULL
isolated	NULL
PB	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
treated	NULL
with	NULL
very	NULL
high	NULL
concentrations	NULL
of	NULL
IL-2	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Because	NULL
TBCs	NULL
are	NULL
derived	NULL
from	NULL
thymic	NULL
tissue	NULL
,	NULL
they	NULL
may	NULL
not	NULL
be	NULL
equivalent	NULL
to	NULL
mature	NULL
PB	NULL
T	NULL
cells	NULL
in	NULL
their	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
by	NULL
IL-2	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
TBCs	NULL
,	NULL
PB	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
after	NULL
culture	NULL
in	NULL
IL-2	NULL
for	NULL
4	NULL
days	NULL
.	NULL

These	NULL
culture	NULL
conditions	NULL
resulted	NULL
in	NULL
a	NULL
population	NULL
of	NULL
pure	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
mature	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
treated	NULL
identically	NULL
to	NULL
TBCs	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
deprived	NULL
,	NULL
and	NULL
then	NULL
restimulated	NULL
with	NULL
IL-2	NULL
or	NULL
PMA	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
evaluated	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
PB	NULL
T	NULL
cells	NULL
also	NULL
did	NULL
not	NULL
activate	NULL
novel	NULL
NF-KB	NULL
binding	NULL
activity	NULL
when	NULL
responding	NULL
to	NULL
IL-2	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
did	NULL
respond	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
by	NULL
progressing	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
46	NULL
%	NULL
of	NULL
cells	NULL
are	NULL
in	NULL
S	NULL
,	NULL
G	NULL
,	NULL
,	NULL
and	NULL
M	NULL
phases	NULL
in	NULL
the	NULL
stimulated	NULL
population	NULL
24	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3311	NULL
A	NULL
-IL-2	NULL
+IL-2	NULL
+PMA	NULL
Ab	NULL
:	NULL
f_	NULL
p50	NULL
-	NULL
RelA	NULL
-	NULL
cRel	NULL
Bcl3	NULL
I	NULL
-	NULL
p50	NULL
RelA	NULL
-	NULL
cRel	NULL
Bcl3	NULL
”	NULL
-	NULL
_	NULL
pSO	NULL
_	NULL
RelA	NULL
-	NULL
cRel	NULL
BC|3|	NULL
P	NULL
,	NULL
1	NULL
®	NULL
S5	NULL
50/RelA	NULL
#	NULL
:	NULL
“	NULL
u	NULL
<	NULL
PsQ/CRE	NULL
i	NULL
:	NULL
wes	NULL
<	NULL
4pS0	NULL
B	NULL
IL-2	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
.5	NULL
1	NULL
2	NULL
8	NULL
12	NULL
24	NULL
ork	NULL
work	NULL
hoo	NULL
thats	NULL
wou	NULL
tout	NULL
tart	NULL
.	NULL

``	NULL
.ﬂ	NULL
n.	NULL
ps0	NULL
tasted	NULL
~	NULL
FIGURE	NULL
3	NULL
.	NULL

IL-2	NULL
does	NULL
not	NULL
induce	NULL
NF-KB	NULL
binding	NULL
activity	NULL
in	NULL
TBCs	NULL
.	NULL

Arrows	NULL
indicate	NULL
complexes	NULL
that	NULL
contain	NULL
the	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
proteins	NULL
and	NULL
SS	NULL
denotes	NULL
supershifted	NULL
species	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
TBC	NULL
preparations	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
analysis	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
TBCs	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
28	NULL
h	NULL
or	NULL
for	NULL
24	NULL
h	NULL
followed	NULL
by	NULL
IL-2	NULL
or	NULL
PMA	NULL
restimulation	NULL
for	NULL
4	NULL
h.	NULL
B	NULL
,	NULL
An	NULL
extensive	NULL
time-course	NULL
analysis	NULL
of	NULL
NF-KB	NULL
binding	NULL
post-IL-2	NULL
restimulation	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Protein	NULL
levels	NULL
in	NULL
the	NULL
extracts	NULL
were	NULL
verified	NULL
by	NULL
analyzing	NULL
binding	NULL
activity	NULL
to	NULL
an	NULL
Oct-1	NULL
probe	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

IL-2	NULL
vs	NULL
14	NULL
%	NULL
of	NULL
the	NULL
IL-2-deprived	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
what	NULL
was	NULL
seen	NULL
with	NULL
IL-2	NULL
,	NULL
PMA	NULL
stimulation	NULL
enhanced	NULL
the	NULL
formation	NULL
of	NULL
complexes	NULL
that	NULL
contained	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
just	NULL
as	NULL
it	NULL
did	NULL
in	NULL
TBCs	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
mature	NULL
T	NULL
cells	NULL
,	NULL
like	NULL
TBCs	NULL
,	NULL
do	NULL
not	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
when	NULL
responding	NULL
to	NULL
IL-2	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
above	NULL
demonstrate	NULL
that	NULL
while	NULL
PMA	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
both	NULL
TBCs	NULL
and	NULL
PB	NULL
T	NULL
cells	NULL
,	NULL
IL-2	NULL
does	NULL
not	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
can	NULL
be	NULL
correlated	NULL
with	NULL
an	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
stimulation	NULL
on	NULL
the	NULL
apoptosis	NULL
seen	NULL
in	NULL
IL-2-deprived	NULL
TBCs	NULL
was	NULL
analyzed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
TBCs	NULL
deprived	NULL
of	NULL
IL-2	NULL
contained	NULL
approximately	NULL
23	NULL
%	NULL
apoptotic	NULL
cells	NULL
,	NULL
and	NULL
IL-2	NULL
stimulation	NULL
decreased	NULL
this	NULL
number	NULL
to	NULL
approximately	NULL
10	NULL
%	NULL
(	NULL
similar	NULL
but	NULL
independent	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Only	NULL
11	NULL
%	NULL
apoptotic	NULL
cells	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
instead	NULL
of	NULL
IL-2	NULL
,	NULL
suggesting	NULL
that	NULL
PMA	NULL
-lL-2	NULL
pSO	NULL
-	NULL
RelA	NULL
a	NULL
F	NULL
+IL-2	NULL
cRel	NULL
Bcl3	NULL
_-	NULL
p50	NULL
RelA	NULL
Ab	NULL
:	NULL
ls	NULL
wilh	NULL
=t	NULL
mycin	NULL
brow	NULL
cans	NULL
With	NULL
Lie	NULL
__	NULL
_	NULL
CO	NULL
r	NULL
T	NULL
is	NULL
almost	NULL
as	NULL
effective	NULL
as	NULL
the	NULL
growth	NULL
factor	NULL
at	NULL
blocking	NULL
apoptotic	NULL
death	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
PMA	NULL
was	NULL
not	NULL
efficient	NULL
at	NULL
inducing	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
while	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
correlate	NULL
with	NULL
an	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
mechanism	NULL
employed	NULL
by	NULL
IL-2	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
a	NULL
Fos/Jun	NULL
heterodimer	NULL
,	NULL
has	NULL
also	NULL
been	NULL
proposed	NULL
to	NULL
save	NULL
many	NULL
cell	NULL
types	NULL
from	NULL
apoptotic	NULL
death	NULL
,	NULL
although	NULL
in	NULL
contrast	NULL
to	NULL
NF-KB	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
Jun	NULL
N-terminal	NULL
kinases	NULL
,	NULL
JNKs	NULL
,	NULL
and	NULL
c-Jun	NULL
has	NULL
also	NULL
been	NULL
proposed	NULL
to	NULL
induce	NULL
apoptotic	NULL
death	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
(	NULL
16-22	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
can	NULL
be	NULL
correlated	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
or	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
IL-2-stimulated	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-2	NULL
activates	NULL
the	NULL
JNK	NULL
pathway	NULL
that	NULL
can	NULL
lead	NULL
to	NULL
transcriptionally	NULL
active	NULL
c-Jun	NULL
,	NULL
JNK	NULL
phosphorylation	NULL
on	NULL
+PMA	NULL
pSO	NULL
RelA	NULL
-	NULL
cRel	NULL
Bc13|	NULL
Yo	NULL
sag	NULL
i	NULL
i	NULL
’	NULL
bos	NULL
~	NULL
fess	NULL
d	NULL
“	NULL
H	NULL
p50/cRel	NULL
b	NULL
-	NULL
l	NULL
<	NULL
4p5so	NULL
Salli	NULL
cRel	NULL
-	NULL
Bcl3	NULL
8	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-2	NULL
does	NULL
not	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
PB	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
confirmatory	NULL
preparation	NULL
of	NULL
PB	NULL
T	NULL
cells	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
to	NULL
verify	NULL
the	NULL
results	NULL
observed	NULL
in	NULL
TBCs	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
47	NULL
h	NULL
(	NULL
-IL-2	NULL
)	NULL
or	NULL
for	NULL
43	NULL
h	NULL
followed	NULL
by	NULL
IL-2	NULL
or	NULL
PMA	NULL
restimulation	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
h	NULL
before	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
.	NULL

Arrows	NULL
indicate	NULL
complexes	NULL
that	NULL
contain	NULL
the	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
proteins	NULL
,	NULL
and	NULL
SS	NULL
denotes	NULL
supershifted	NULL
species	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3312	NULL
Table	NULL
I.	NULL
PMA	NULL
effeciently	NULL
relieves	NULL
apoptosis	NULL
but	NULL
not	NULL
cell	NULL
cycle	NULL
synchronization	NULL
in	NULL
TBCs	NULL
deprived	NULL
of	NULL
IL-2	NULL
Treatment	NULL
Gy/G	NULL
,	NULL
``	NULL
s	NULL
G	NULL
,	NULL
+M	NULL
_	NULL
TUNEL+®	NULL
IL-2	NULL
deprived	NULL
927+	NULL
0.9	NULL
4.5	NULL
+06	NULL
2.8	NULL
£	NULL
0.6	NULL
23.2	NULL
+10	NULL
IL-2	NULL
restimulated	NULL
65.2	NULL
+	NULL
8.4	NULL
29.6	NULL
+	NULL
7.5	NULL
5.2	NULL
%	NULL
1.5	NULL
9.9	NULL
*	NULL
#	NULL
4.6	NULL
PMA	NULL
restimulated	NULL
83.3	NULL
+	NULL
13	NULL
10.1	NULL
+	NULL
6.7	NULL
6.6	NULL
+	NULL
6.6	NULL
10.8	NULL
£4.6	NULL
*	NULL
Numbers	NULL
given	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
(	NULL
cell	NULL
cycle	NULL
)	NULL
or	NULL
five	NULL
(	NULL
apoptosis	NULL
)	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
standard	NULL
deviations	NULL
are	NULL
shown	NULL
.	NULL

threonine	NULL
183/tyrosine	NULL
185	NULL
was	NULL
analyzed	NULL
in	NULL
TBCs	NULL
stimulated	NULL
with	NULL
IL-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
significant	NULL
phosphorylation	NULL
of	NULL
JNK	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
TBCs	NULL
,	NULL
suggesting	NULL
that	NULL
AP-1	NULL
can	NULL
not	NULL
be	NULL
activated	NULL
by	NULL
IL-2	NULL
.	NULL

Anisomysin	NULL
,	NULL
a	NULL
known	NULL
activator	NULL
of	NULL
the	NULL
SEK/JNK	NULL
pathway	NULL
,	NULL
did	NULL
induce	NULL
JNK	NULL
phosphorylation	NULL
in	NULL
TBCs	NULL
,	NULL
demonstrating	NULL
that	NULL
JNK	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
and	NULL
STAT5	NULL
,	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
both	NULL
primary	NULL
T	NULL
cells	NULL
and	NULL
IL-2-responsive	NULL
cell	NULL
lines	NULL
(	NULL
28-33	NULL
)	NULL
,	NULL
was	NULL
readily	NULL
observed	NULL
in	NULL
IL-2-stimulated	NULL
TBCs	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
AP-1	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
TBC	NULL
's	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
cells	NULL
restimulated	NULL
with	NULL
IL-2	NULL
or	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
AP-1	NULL
binding	NULL
activity	NULL
to	NULL
a	NULL
consensus	NULL
TRE	NULL
sequence	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
although	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
TRE	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
restimulation	NULL
(	NULL
1.5-fold	NULL
when	NULL
corrected	NULL
for	NULL
Oct	NULL
binding	NULL
activity	NULL
)	NULL
,	NULL
IL-2	NULL
did	NULL
not	NULL
induce	NULL
in	NULL
TBCs	NULL
the	NULL
formation	NULL
of	NULL
novel	NULL
TRE-specific	NULL
binding	NULL
activity	NULL
over	NULL
that	NULL
observed	NULL
in	NULL
cells	NULL
deprived	NULL
of	NULL
IL-2	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
c-Fos	NULL
was	NULL
not	NULL
present	NULL
in	NULL
the	NULL
TRE-specific	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
observed	NULL
,	NULL
demonstrating	NULL
that	NULL
AP-1	NULL
was	NULL
not	NULL
present	NULL
.	NULL

IL-2	NULL
(	NULL
min	NULL
)	NULL
Aniso	NULL
0	NULL
10	NULL
20	NULL
30	NULL
60	NULL
10	NULL
20	NULL
e=	NULL
#	NULL
-	NULL
PO4	NULL
*	NULL
JNKs	NULL
Total	NULL
JNKs	NULL
n—u	NULL
.	NULL

--	NULL
-—-—u—__.—	NULL
--	NULL
E	NULL
e	NULL
wate	NULL
wah	NULL
4-	NULL
VC	NULL
4	NULL
``	NULL
at	NULL
,	NULL
*	NULL
Stat3	NULL
Total	NULL
smain	NULL
Eads	NULL
case	NULL
lb	NULL
f-	NULL
‘	NULL
Stat3	NULL
PO4	NULL
**	NULL
summ	NULL
``	NULL
cng	NULL
-ma	NULL
``	NULL
®	NULL
*	NULL
Stat5	NULL
ve	NULL
comity	NULL
4/02	NULL
Stat5	NULL
FIGURE	NULL
5	NULL
.	NULL

IL-2	NULL
stimulation	NULL
of	NULL
TBCs	NULL
results	NULL
in	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
and	NULL
STAT5	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
1/2	NULL
.	NULL

Total	NULL
protein	NULL
was	NULL
isolated	NULL
from	NULL
TBCs	NULL
deprived	NULL
of	NULL
IL-2	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
restimulated	NULL
with	NULL
IL-2	NULL
or	NULL
anisomysin	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Protein	NULL
(	NULL
50-75	NULL
pg/lane	NULL
)	NULL
was	NULL
loaded	NULL
and	NULL
probed	NULL
for	NULL
either	NULL
phosphorylated	NULL
JNK	NULL
1/2	NULL
or	NULL
phosphorylated	NULL
STAT3	NULL
and	NULL
STATS	NULL
using	NULL
specific	NULL
antisera	NULL
.	NULL

Total	NULL
protein	NULL
levels	NULL
were	NULL
determined	NULL
for	NULL
all	NULL
molecules	NULL
by	NULL
stripping	NULL
and	NULL
reprobing	NULL
the	NULL
filters	NULL
with	NULL
antisera	NULL
recognizing	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
forms	NULL
of	NULL
JNK1/2	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATS	NULL
as	NULL
applicable	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
TBC	NULL
preparations	NULL
.	NULL

LACK	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
AP-1	NULL
ACTIVATION	NULL
BY	NULL
IL-2	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
induced	NULL
strong	NULL
TRE	NULL
bind-ing	NULL
,	NULL
which	NULL
was	NULL
due	NULL
to	NULL
AP-1	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
c-Fos	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
PB	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
that	NULL
PMA	NULL
and	NULL
ionomycin	NULL
strongly	NULL
induced	NULL
TRE-specific	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
includes	NULL
c-Fos	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
TRE	NULL
binding	NULL
in	NULL
PB	NULL
T	NULL
cells	NULL
over	NULL
that	NULL
observed	NULL
in	NULL
IL-2-deprived	NULL
cells	NULL
and	NULL
did	NULL
not	NULL
induce	NULL
c-Fos	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
along	NULL
with	NULL
the	NULL
evidence	NULL
that	NULL
JNK	NULL
is	NULL
not	NULL
activated	NULL
strongly	NULL
suggest	NULL
that	NULL
IL-2	NULL
does	NULL
not	NULL
use	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
to	NULL
promote	NULL
cell	NULL
cycle	NULL
progression	NULL
or	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Discussion	NULL
Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
(	NULL
5-9	NULL
;	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Because	NULL
IL-2	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
addition	NULL
to	NULL
inducing	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
it	NULL
is	NULL
logical	NULL
to	NULL
propose	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
occurs	NULL
after	NULL
IL-2	NULL
stimulation	NULL
and	NULL
that	NULL
this	NULL
mechanism	NULL
is	NULL
important	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
found	NULL
that	NULL
IL-2	NULL
does	NULL
activate	NULL
NF-KB	NULL
in	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
freshly	NULL
isolated	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
factor	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-2	NULL
is	NULL
known	NULL
to	NULL
transcriptionally	NULL
up-regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
-chain	NULL
gene	NULL
,	NULL
and	NULL
it	NULL
is	NULL
known	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
promoter	NULL
by	NULL
TCR/CD3	NULL
stimulation	NULL
requires	NULL
NF-KB	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
recently	NULL
discovered	NULL
that	NULL
the	NULL
IL-2	NULL
response	NULL
element	NULL
in	NULL
the	NULL
IL-2R	NULL
-chain	NULL
promoter	NULL
is	NULL
a	NULL
STATS	NULL
binding	NULL
site	NULL
instead	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
NF-	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
IL-2	NULL
does	NULL
not	NULL
need	NULL
to	NULL
activate	NULL
NF-KB	NULL
to	NULL
up-regu-late	NULL
this	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
IL-2	NULL
does	NULL
not	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
response	NULL
to	NULL
high	NULL
concentrations	NULL
of	NULL
IL-2	NULL
,	NULL
are	NULL
probably	NULL
not	NULL
the	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
in	NULL
vivo	NULL
,	NULL
because	NULL
they	NULL
do	NULL
not	NULL
express	NULL
the	NULL
high	NULL
affinity	NULL
receptor	NULL
.	NULL

In	NULL
previously	NULL
activated	NULL
T	NULL
cells	NULL
that	NULL
already	NULL
express	NULL
the	NULL
high	NULL
affinity	NULL
receptor	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IL-2	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
occur	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
clearly	NULL
demonstrate	NULL
that	NULL
NF-KB	NULL
activation	NULL
is	NULL
not	NULL
obligatory	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
that	NULL
respond	NULL
to	NULL
IL-2	NULL
by	NULL
both	NULL
progressing	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
avoiding	NULL
apoptosis	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
PMA	NULL
both	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
inhibits	NULL
apoptosis	NULL
suggests	NULL
that	NULL
this	NULL
transcription	NULL
factor	NULL
may	NULL
block	NULL
death	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
have	NULL
supported	NULL
the	NULL
observation	NULL
that	NULL
NF-KB	NULL
is	NULL
activated	NULL
when	NULL
human	NULL
T	NULL
cells	NULL
are	NULL
stimulated	NULL
through	NULL
the	NULL
Ag	NULL
receptor	NULL
,	NULL
and	NULL
it	NULL
may	NULL
be	NULL
particularly	NULL
important	NULL
to	NULL
survival	NULL
signals	NULL
in	NULL
these	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
during	NULL
development	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
processes	NULL
,	NULL
however	NULL
,	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
involve	NULL
IL-2	NULL
and	NULL
are	NULL
probably	NULL
not	NULL
relevant	NULL
to	NULL
mature	NULL
T	NULL
cells	NULL
proliferating	NULL
solely	NULL
in	NULL
response	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
.	NULL

It	NULL
does	NULL
appear	NULL
that	NULL
protection	NULL
from	NULL
apoptosis	NULL
via	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
may	NULL
be	NULL
important	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
that	NULL
grow	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Because	NULL
IL-2	NULL
does	NULL
not	NULL
inhibit	NULL
apoptosis	NULL
or	NULL
induce	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
IL-2R	NULL
signaling	NULL
pathways	NULL
may	NULL
be	NULL
subverted	NULL
in	NULL
some	NULL
immortalized	NULL
cell	NULL
lines	NULL
.	NULL

These	NULL
unnatural	NULL
signaling	NULL
pathways	NULL
may	NULL
be	NULL
very	NULL
important	NULL
to	NULL
the	NULL
immortalization	NULL
and/or	NULL
transformation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
but	NULL
this	NULL
subversion	NULL
may	NULL
provide	NULL
misleading	NULL
results	NULL
in	NULL
the	NULL
study	NULL
of	NULL
IL-2R	NULL
signaling	NULL
when	NULL
applied	NULL
to	NULL
the	NULL
events	NULL
that	NULL
occur	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
are	NULL
up-regulated	NULL
by	NULL
IL-2	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
obvious	NULL
conclusion	NULL
that	NULL
AP-1	NULL
activity	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
biologic	NULL
consequences	NULL
of	NULL
IL-2	NULL
stimulation	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
Ca*	NULL
*	NULL
-dependent	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3313	NULL
IL-2	NULL
(	NULL
hr	NULL
)	NULL
PMA	NULL
(	NULL
hr	NULL
)	NULL
0	NULL
2	NULL
4	NULL
8	NULL
2	NULL
4	NULL
P	NULL
-	NULL
TRE	NULL
FIGURE	NULL
6	NULL
.	NULL

PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
but	NULL
not	NULL
IL-2	NULL
,	NULL
activate	NULL
AP-1	NULL
binding	NULL
in	NULL
TBCs	NULL
and	NULL
PB	NULL
T	NULL
cells	NULL
.	NULL

EMSA	NULL
analysis	NULL
using	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
TBCs	NULL
(	NULL
4	NULL
)	NULL
or	NULL
PB	NULL
T	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
de-	NULL
prived	NULL
of	NULL
IL-2	NULL
(	NULL
-IL-2	NULL
)	NULL
or	NULL
restimulated	NULL
with	NULL
IL-2	NULL
or	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
the	NULL
times	NULL
noted	NULL
(	NULL
4	NULL
)	NULL
or	NULL
for	NULL
4	NULL
h	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
in	NULL
dicates	NULL
the	NULL
TRE-specific	NULL
complex	NULL
that	NULL
con-	NULL
B	NULL
tains	NULL
c-Fos	NULL
.	NULL

SS	NULL
denotes	NULL
the	NULL
supershifted	NULL
spe-	NULL
|	NULL
cies	NULL
.	NULL

In	NULL
lanes	NULL
denoted	NULL
TRE	NULL
and	NULL
Fos	NULL
,	NULL
a	NULL
200-	NULL
P	NULL
®	NULL
fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
TRE	NULL
DNA	NULL
or	NULL
c-Fos	NULL
specific	NULL
antiserum	NULL
was	NULL
added	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
to	NULL
demonstrate	NULL
the	NULL
spec	NULL
ificity	NULL
of	NULL
the	NULL
complexes	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
c-Fos	NULL
protein	NULL
.	NULL

C	NULL
,	NULL
The	NULL
levels	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
nuclear	NULL
extract	NULL
were	NULL
controlled	NULL
for	NULL
load	NULL
ing	NULL
by	NULL
Oct	NULL
binding	NULL
.	NULL

Differences	NULL
in	NULL
protein	NULL
lev-	NULL
els	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
differences	NULL
in	NULL
Oct	NULL
bind	NULL
ing	NULL
,	NULL
are	NULL
responsible	NULL
for	NULL
much	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
increased	NULL
TRE	NULL
binding	NULL
observed	NULL
in	NULL
TBC	NULL
C	NULL
-IL-2	NULL
TRE	NULL
aFos	NULL
_	NULL
I	NULL
TRE	NULL
uFos	NULL
=	NULL
=	NULL
TRE	NULL
aFos	NULL
4-SS	NULL
Ui	NULL
bes	NULL
UH	NULL
“	NULL
.	NULL
'	NULL

W*	NULL
+I1L-2	NULL
II	NULL
TRE	NULL
aFDS	NULL
”	NULL
=	NULL
PMA	NULL
+	NULL
ion	NULL
TRE	NULL
uFOSI	NULL
4-SS	NULL
4-AP-1	NULL
(	NULL
e	NULL
``	NULL
|	NULL
extracts	NULL
.	NULL

The	NULL
experiments	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
T	NULL
cell	NULL
preparations	NULL
[	NULL
(	NULL
three	NULL
thymic	NULL
and	NULL
one	NULL
PB	NULL
)	NULL
.	NULL

0	NULL
mus	NULL
ct	NULL
rt	NULL
>	NULL
>	NULL
phosphatase	NULL
calcineurin	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
47-49	NULL
)	NULL
,	NULL
and	NULL
IL-2	NULL
does	NULL
not	NULL
induce	NULL
a	NULL
Ca**	NULL
flux	NULL
(	NULL
3	NULL
)	NULL
,	NULL
it	NULL
is	NULL
logical	NULL
to	NULL
predict	NULL
that	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
IL-2	NULL
stimulation	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
here	NULL
that	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
the	NULL
result	NULL
of	NULL
IL-2	NULL
stimulation	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
nor	NULL
is	NULL
AP-1	NULL
binding	NULL
activity	NULL
observed	NULL
up	NULL
to	NULL
8	NULL
h	NULL
poststimulation	NULL
.	NULL

However	NULL
,	NULL
JNK	NULL
activation	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
IL-2	NULL
stimulation	NULL
in	NULL
some	NULL
factor-dependent	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Another	NULL
study	NULL
demonstrated	NULL
that	NULL
HTLV-1-transformed	NULL
cells	NULL
contain	NULL
constitutively	NULL
active	NULL
JNK	NULL
,	NULL
but	NULL
that	NULL
IL-2-dependent	NULL
cell	NULL
lines	NULL
immortalized	NULL
by	NULL
HTLV-1	NULL
infection	NULL
do	NULL
not	NULL
contain	NULL
active	NULL
JNK	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
26	NULL
)	NULL
.	NULL

It	NULL
was	NULL
concluded	NULL
from	NULL
this	NULL
latter	NULL
study	NULL
that	NULL
IL-2	NULL
activates	NULL
JNK	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
constitutive	NULL
activation	NULL
of	NULL
JNK	NULL
is	NULL
an	NULL
essential	NULL
step	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
IL-2	NULL
independence	NULL
required	NULL
for	NULL
transformation	NULL
.	NULL

Because	NULL
IL-2	NULL
does	NULL
not	NULL
activate	NULL
JNK	NULL
in	NULL
primary	NULL
cells	NULL
,	NULL
JNK	NULL
activation	NULL
by	NULL
IL-2	NULL
may	NULL
somehow	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
immortalization	NULL
process	NULL
these	NULL
cell	NULL
lines	NULL
have	NULL
under-gone	NULL
,	NULL
related	NULL
to	NULL
either	NULL
HTLV-1	NULL
infection	NULL
or	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
Tax	NULL
protein	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
IL-2R	NULL
signaling	NULL
may	NULL
be	NULL
subverted	NULL
in	NULL
at	NULL
least	NULL
some	NULL
cell	NULL
lines	NULL
responding	NULL
to	NULL
the	NULL
growth	NULL
factor	NULL
.	NULL

This	NULL
observation	NULL
requires	NULL
that	NULL
caution	NULL
be	NULL
used	NULL
when	NULL
inferring	NULL
that	NULL
results	NULL
obtained	NULL
with	NULL
these	NULL
cells	NULL
can	NULL
be	NULL
applied	NULL
to	NULL
nontransformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
still	NULL
unclear	NULL
what	NULL
mechanisms	NULL
are	NULL
responsible	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
.	NULL

Previous	NULL
studies	NULL
,	NULL
such	NULL
as	NULL
those	NULL
discussed	NULL
above	NULL
,	NULL
demonstrating	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
be	NULL
protective	NULL
against	NULL
apoptosis	NULL
strongly	NULL
suggest	NULL
that	NULL
transcription	NULL
is	NULL
required	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

By	NULL
ruling	NULL
out	NULL
the	NULL
involvement	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
biological	NULL
consequences	NULL
of	NULL
IL-2	NULL
stimulation	NULL
,	NULL
other	NULL
transcription	NULL
factors	NULL
may	NULL
now	NULL
become	NULL
the	NULL
focus	NULL
of	NULL
investigation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
E2F	NULL
transcription	NULL
factor	NULL
is	NULL
activated	NULL
by	NULL
IL-2	NULL
and	NULL
that	NULL
this	NULL
is	NULL
mediated	NULL
by	NULL
phosphoinositol	NULL
3-kinase	NULL
(	NULL
PI-3K	NULL
)	NULL
(	NULL
50	NULL
)	NULL
,	NULL
a	NULL
kinase	NULL
well	NULL
established	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
the	NULL
growth	NULL
factor	NULL
(	NULL
3	NULL
)	NULL
.	NULL

PI-3K	NULL
is	NULL
known	NULL
to	NULL
activate	NULL
the	NULL
MEK/ERK	NULL
(	NULL
mitogen-activated	NULL
protein/extracellular	NULL
signal-reg-ulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
kinase	NULL
)	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
(	NULL
51	NULL
)	NULL
,	NULL
but	NULL
it	NULL
also	NULL
activates	NULL
AKT/PKB	NULL
(	NULL
protein	NULL
kinase	NULL
B	NULL
)	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
tested	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

52	NULL
and	NULL
53	NULL
)	NULL
,	NULL
and	NULL
this	NULL
kinase	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
both	NULL
cell	NULL
cycle	NULL
progression	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
(	NULL
54	NULL
)	NULL
.	NULL

E2F	NULL
activation	NULL
requires	NULL
AKT	NULL
,	NULL
but	NULL
not	NULL
ERK	NULL
,	NULL
and	NULL
correlates	NULL
well	NULL
with	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
,	NULL
although	NULL
it	NULL
is	NULL
not	NULL
sufficient	NULL
in	NULL
and	NULL
of	NULL
itself	NULL
to	NULL
induce	NULL
proliferation	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Whether	NULL
E2F	NULL
or	NULL
,	NULL
al-ternatively	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
that	NULL
might	NULL
be	NULL
induced	NULL
by	NULL
AKT	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
mediated	NULL
by	NULL
IL-2	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
.	NULL

As	NULL
noted	NULL
above	NULL
,	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
is	NULL
also	NULL
stimulated	NULL
by	NULL
IL-2	NULL
(	NULL
28	NULL
,	NULL
30-33	NULL
,	NULL
55-58	NULL
)	NULL
.	NULL

Both	NULL
STAT3	NULL
and	NULL
STATS	NULL
are	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-2	NULL
,	NULL
and	NULL
indeed	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
is	NULL
readily	NULL
observable	NULL
in	NULL
TBC	NULL
's	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Zamorano	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
recently	NULL
reported	NULL
that	NULL
STATS	NULL
is	NULL
required	NULL
for	NULL
protection	NULL
from	NULL
apoptosis	NULL
but	NULL
not	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
32D	NULL
cells	NULL
expressing	NULL
the	NULL
IL-2R	NULL
.	NULL

Additional	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
STAT	NULL
's	NULL
are	NULL
not	NULL
required	NULL
for	NULL
proliferation	NULL
induced	NULL
by	NULL
IL-2	NULL
(	NULL
31	NULL
,	NULL
60	NULL
)	NULL
,	NULL
but	NULL
T	NULL
cells	NULL
from	NULL
STAT-5A-deficient	NULL
mice	NULL
have	NULL
a	NULL
proliferative	NULL
defect	NULL
(	NULL
44	NULL
)	NULL
.	NULL

STATS	NULL
is	NULL
required	NULL
for	NULL
IL-2-mediated	NULL
IL-2Ra	NULL
expression	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
but	NULL
decreased	NULL
high	NULL
affinity	NULL
receptor	NULL
expression	NULL
may	NULL
not	NULL
be	NULL
entirely	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3314	NULL
responsible	NULL
for	NULL
the	NULL
decrease	NULL
in	NULL
proliferation	NULL
observed	NULL
in	NULL
STAT5A-deficient	NULL
mice	NULL
(	NULL
61	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
studies	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
may	NULL
not	NULL
always	NULL
agree	NULL
with	NULL
what	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
immortalized	NULL
murine	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
what	NULL
else	NULL
STAT-deficient	NULL
mice	NULL
will	NULL
reveal	NULL
about	NULL
IL-2R	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
determine	NULL
whether	NULL
STAT	NULL
proteins	NULL
are	NULL
included	NULL
among	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
important	NULL
for	NULL
IL-2-mediated	NULL
cell	NULL
cycle	NULL
progression	NULL
or	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Either	NULL
way	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
IL-2	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
must	NULL
be	NULL
involved	NULL
in	NULL
these	NULL
events	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
responding	NULL
to	NULL
IL-2	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Chiron	NULL
Corp.	NULL
for	NULL
rIL-2	NULL
,	NULL
New	NULL
England	NULL
Biolabs	NULL
for	NULL
antisera	NULL
specific	NULL
for	NULL
phosphorylated	NULL
STATS5	NULL
,	NULL
Dr.	NULL
Constantine	NULL
Tsoukas	NULL
for	NULL
helpful	NULL
dis-cussion	NULL
,	NULL
Dennis	NULL
Young	NULL
of	NULL
the	NULL
Stem	NULL
Cell	NULL
Laboratory	NULL
at	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Diego	NULL
for	NULL
assistance	NULL
with	NULL
FACS	NULL
analysis	NULL
,	NULL
and	NULL
Carol	NULL
Worden	NULL
and	NULL
the	NULL
staff	NULL
of	NULL
the	NULL
operating	NULL
room	NULL
at	NULL
Children	NULL
's	NULL
Hospital	NULL
of	NULL
San	NULL
Diego	NULL
for	NULL
thymic	NULL
specimens	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1980	NULL
.	NULL

T-cell	NULL
growth	NULL
factor	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

51:337	NULL
.	NULL

2	NULL
.	NULL

Robb	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1984	NULL
.	NULL

Interleukin	NULL
2	NULL
:	NULL
the	NULL
molecule	NULL
and	NULL
its	NULL
function	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
5:203	NULL
.	NULL

3	NULL
.	NULL

Karnitz	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Abraham	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
signaling	NULL
mechanisms	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

61:147	NULL
.	NULL

4	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045	NULL
.	NULL

5	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
essential	NULL
role	NULL
for	NULL
NF-B	NULL
in	NULL
preventing	NULL
TNF-a-induced	NULL
cell	NULL
death	NULL
.	NULL

Science	NULL
274:782	NULL
.	NULL

6	NULL
.	NULL

Liu	NULL
,	NULL
Z.-G.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
D.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-KB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87:565	NULL
.	NULL

7	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
J.	NULL
Martin	NULL
,	NULL
T.	NULL
Kafri	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1996	NULL
.	NULL

Suppression	NULL
of	NULL
TNF-a-induced	NULL
apoptosis	NULL
by	NULL
NF-KB	NULL
.	NULL

Science	NULL
274:787	NULL
.	NULL

8	NULL
.	NULL

Wang	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
Walsh	NULL
.	NULL

1996	NULL
.	NULL

Resistance	NULL
to	NULL
apoptosis	NULL
conferred	NULL
by	NULL
cdk	NULL
inhibitors	NULL
during	NULL
myocyte	NULL
differentiation	NULL
.	NULL

Science	NULL
273:359	NULL
.	NULL

9	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Lee	NULL
,	NULL
R.	NULL
E.	NULL
Bellas	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
M.	NULL
Arsura	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
M.	NULL
J.	NULL
FitzGerald	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
D.	NULL
H.	NULL
Sherr	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
Rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4682	NULL
.	NULL

10	NULL
.	NULL

Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1997	NULL
.	NULL

Apoptosis	NULL
:	NULL
activate	NULL
NF-KB	NULL
or	NULL
dic	NULL
?	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
R94	NULL
.	NULL

11	NULL
.	NULL

Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
1997	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
control	NULL
of	NULL
apoptosis	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

8:113	NULL
.	NULL

12	NULL
.	NULL

Duke	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Cohen	NULL
.	NULL

1986	NULL
.	NULL

IL-2	NULL
addition	NULL
:	NULL
withdrawal	NULL
of	NULL
growth	NULL
factor	NULL
activates	NULL
a	NULL
suicide	NULL
program	NULL
in	NULL
dependent	NULL
T	NULL
cells	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

5:289	NULL
.	NULL

13	NULL
.	NULL

Raff	NULL
,	NULL
M.	NULL
C.	NULL
1992	NULL
.	NULL

Social	NULL
controls	NULL
on	NULL
cell	NULL
survival	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Nature	NULL
356:397	NULL
.	NULL

14	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
W.	NULL
A.	NULL
Kuziel	NULL
,	NULL
T.	NULL
A.	NULL
Grdina	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

IL-2-induced	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:83	NULL
.	NULL

15	NULL
.	NULL

Xie	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
J.	NULL
Seward	NULL
,	NULL
and	NULL
B.	NULL
T.	NULL
Huber	NULL
.	NULL

1997	NULL
.	NULL

Cytokine	NULL
rescue	NULL
from	NULL
glucocorticoid	NULL
induced	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
through	NULL
inhibition	NULL
of	NULL
IxBa	NULL
.	NULL

Mol	NULL
.	NULL

Immunol	NULL
.	NULL

34:987	NULL
.	NULL

16	NULL
.	NULL

Schreiber	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Baumann	NULL
,	NULL
M.	NULL
Cotton	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Wanger	NULL
.	NULL

1995	NULL
.	NULL

Fos	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
mammalian	NULL
UV	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:5338	NULL
.	NULL

17	NULL
.	NULL

Ivanov	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
and	NULL
J.	NULL
Nikolic-Zugic	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
activation	NULL
during	NULL
signal-induced	NULL
apoptosis	NULL
of	NULL
immature	NULL
CD4*	NULL
CD8	NULL
*	NULL
thymocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:8558	NULL
.	NULL

18	NULL
.	NULL

Colotta	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Polentarutti	NULL
,	NULL
M.	NULL
Sironi	NULL
,	NULL
and	NULL
A.	NULL
Mantovani	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
and	NULL
involvement	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
protooncogenes	NULL
in	NULL
programmed	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:18278	NULL
.	NULL

19	NULL
.	NULL

Smeyne	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
M.	NULL
Vendrell	NULL
,	NULL
M.	NULL
Hayward	NULL
,	NULL
S.	NULL
J.	NULL
Baker	NULL
,	NULL
G.	NULL
G.	NULL
Miao	NULL
,	NULL
K.	NULL
Schilling	NULL
,	NULL
L.	NULL
Robertson	NULL
M.	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
J.	NULL
Morgan	NULL
.	NULL

1993	NULL
.	NULL

Continuous	NULL
c-fos	NULL
expression	NULL
precedes	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Nature	NULL
363:166	NULL
.	NULL

20	NULL
.	NULL

Ham	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Babij	NULL
,	NULL
J.	NULL
Whitfield	NULL
,	NULL
C.	NULL
M.	NULL
Pfarr	NULL
,	NULL
D.	NULL
Lallemand	NULL
,	NULL
M.	NULL
Yaniv	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Rubin	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
c-Jun	NULL
dominant	NULL
negative	NULL
mutant	NULL
protects	NULL
sympathetic	NULL
neurons	NULL
against	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Neuron	NULL
14:927	NULL
.	NULL

21	NULL
.	NULL

Xia	NULL
,	NULL
Z.	NULL
,	NULL
M.	NULL
Dickens	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
E.	NULL
1995	NULL
.	NULL

Opposing	NULL
effects	NULL
of	NULL
ERK	NULL
and	NULL
JNK-p38	NULL
MAP	NULL
kinases	NULL
on	NULL
apoptosis	NULL
.	NULL

Science	NULL
270:1326	NULL
.	NULL

22	NULL
.	NULL

Verheij	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Bose	NULL
,	NULL
X.	NULL
H.	NULL
Lin	NULL
,	NULL
B.	NULL
Yao	NULL
,	NULL
W.	NULL
D.	NULL
Jarvis	NULL
,	NULL
S.	NULL
Grant	NULL
,	NULL
M.	NULL
J.	NULL
Birrer	NULL
,	NULL
E.	NULL
Szabo	NULL
,	NULL
L.	NULL
I.	NULL
Zon	NULL
,	NULL
J.	NULL
M.	NULL
Kyriakis	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
for	NULL
ceramide-initiated	NULL
SAPK/JINK	NULL
signalling	NULL
in	NULL
stress-induced	NULL
apoptosis	NULL
.	NULL

Nature	NULL
380:75	NULL
.	NULL

23	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Zheng-gang	NULL
,	NULL
and	NULL
E.	NULL
Zandi	NULL
.	NULL

1997	NULL
.	NULL

AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9:240	NULL
.	NULL

24	NULL
.	NULL

Poletta	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
D.	NULL
H.	NULL
Segal	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Cohen	NULL
.	NULL

1998	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
:	NULL
all	NULL
roads	NULL
lead	NULL
to	NULL
AP-1	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

63:139	NULL
.	NULL

25	NULL
.	NULL

Guizani	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Perrin-Wolff	NULL
,	NULL
J.	NULL
Breard	NULL
,	NULL
B.	NULL
Binctruy	NULL
,	NULL
and	NULL
J.	NULL
Bertoglio	NULL
.	NULL

1996	NULL
.	NULL

Mechanisms	NULL
of	NULL
interleukin-2	NULL
protection	NULL
against	NULL
glucocorticoid-induced	NULL
apopto-	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

LACK	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
AND	NULL
AP-1	NULL
ACTIVATION	NULL
BY	NULL
IL-2	NULL
sis	NULL
:	NULL
regulation	NULL
of	NULL
AP-1	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
transcriptional	NULL
activities	NULL
.	NULL

J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

16:601	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
0	NULL
.	NULL

Heidenreich	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
Q.	NULL
Li	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1996	NULL
.	NULL

Constitutively	NULL
activated	NULL
JNK	NULL
is	NULL
associated	NULL
with	NULL
HTLV-1	NULL
mediated	NULL
tumor-igenesis	NULL
.	NULL

Oncogene	NULL
12:135	NULL
.	NULL

Crawley	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
L.	NULL
Rawlinson	NULL
,	NULL
F.	NULL
V.	NULL
Lali	NULL
,	NULL
T.	NULL
H.	NULL
Page	NULL
,	NULL
J.	NULL
Saklatvala	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
J.	NULL
Foxwell	NULL
.	NULL

1997	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
interleukins	NULL
2	NULL
and	NULL
7	NULL
requires	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:15023	NULL
.	NULL

Nielsen	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Svejgaard	NULL
,	NULL
S.	NULL
Skov	NULL
,	NULL
and	NULL
N.	NULL
Odum	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
Stat3	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:3082	NULL
.	NULL

Rothman	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Kreider	NULL
,	NULL
M.	NULL
Azam	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
U.	NULL
Wegenka	NULL
,	NULL
A.	NULL
Eilers	NULL
,	NULL
T.	NULL
Decker	NULL
,	NULL
F.	NULL
Horn	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
J.	NULL
Thile	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Cytokines	NULL
and	NULL
growth	NULL
factors	NULL
signal	NULL
through	NULL
tyrosines	NULL
phosphorylation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
.	NULL

Immunity	NULL
1:457	NULL
.	NULL

Brunn	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
E.	NULL
L.	NULL
Falls	NULL
,	NULL
A.	NULL
E.	NULL
Nilson	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Abraham	NULL
.	NULL

1995	NULL
.	NULL

Protein-tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
STAT	NULL
transcription	NULL
factors	NULL
in	NULL
interleukin-2-or	NULL
in-terleukin-4-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11628	NULL
.	NULL

Fujii	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Mori	NULL
,	NULL
F.	NULL
Gouilleux	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
J.	NULL
N.	NULL
Thile	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
T.	NULL
Miyazaki	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
Stat5	NULL
by	NULL
interleukin	NULL
2	NULL
requires	NULL
a	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
B	NULL
chain	NULL
but	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
the	NULL
proliferative	NULL
signal	NULL
transmission	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:5482	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Schindler	NULL
,	NULL
W.	NULL
J.	NULL
Henzel	NULL
,	NULL
S.	NULL
C.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Immunity	NULL
2:321	NULL
.	NULL

Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
T.-S.	NULL
Migone	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Weatherbee	NULL
,	NULL
L.	NULL
Zhou	NULL
,	NULL
A.	NULL
Yamauchi	NULL
,	NULL
E.	NULL
T.	NULL
Bloom	NULL
,	NULL
J.	NULL
Mictz	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
Stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiot-ropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2:331	NULL
.	NULL

Rohwer	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Todd	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
McGuire	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-2	NULL
treatment	NULL
on	NULL
transcriptional	NULL
attenuation	NULL
in	NULL
proto-oncogenes	NULL
pim-1	NULL
and	NULL
c-myb	NULL
in	NULL
human	NULL
thymic	NULL
blast	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:643	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Iacobelli	NULL
.	NULL

1997	NULL
.	NULL

Involvement	NULL
of	NULL
Rel	NULL
,	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
in	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
CD28	NULL
response	NULL
element/AP-1	NULL
sequence	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
nmunol	NULL
.	NULL

159:1319	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

The	NULL
NF-kB	NULL
and	NULL
IB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
M.	NULL
Koedood	NULL
,	NULL
K.	NULL
A.	NULL
Piffat	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
White	NULL
.	NULL

1996	NULL
.	NULL

IkB	NULL
proteins	NULL
and	NULL
cancer	NULL
.	NULL

Oncogene	NULL
13:1367	NULL
.	NULL

Imbert	NULL
,	NULL
V.	NULL
,	NULL
R.	NULL
A.	NULL
Rupec	NULL
,	NULL
A.	NULL
Livolsi	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
E.	NULL
B.-M.	NULL
Traenckner	NULL
,	NULL
C.	NULL
Mueller-Dieckmann	NULL
,	NULL
D.	NULL
Farahifar	NULL
,	NULL
B.	NULL
Rossi	NULL
,	NULL
P.	NULL
Auberger	NULL
,	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
IkB-a	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxB	NULL
.	NULL

Cell	NULL
86:787	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
V.	NULL
Azarenko	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
oncoprotein	NULL
Bcl-3	NULL
directly	NULL
transactivates	NULL
through	NULL
xB	NULL
motifs	NULL
via	NULL
association	NULL
with	NULL
DNA-binding	NULL
p50OB	NULL
homodimers	NULL
.	NULL

Cell	NULL
72:729	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
M.	NULL
L.	NULL
Scott	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
candidate	NULL
proto-oncogene	NULL
bel-3	NULL
encodes	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
that	NULL
activates	NULL
through	NULL
NF-B	NULL
p50	NULL
homodimers	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1354	NULL
.	NULL

Watanabe	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
Iwamura	NULL
,	NULL
T.	NULL
Shinoda	NULL
,	NULL
and	NULL
T.	NULL
Fujita	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
NFKB1	NULL
proteins	NULL
by	NULL
the	NULL
candidate	NULL
oncoprotein	NULL
BCL-3	NULL
:	NULL
generation	NULL
of	NULL
NF-KB	NULL
homodimers	NULL
from	NULL
the	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
pS0-p105	NULL
and	NULL
nuclear	NULL
translocation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3609	NULL
.	NULL

Lecine	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Algarte	NULL
,	NULL
P.	NULL
Rameil	NULL
,	NULL
C.	NULL
Beadling	NULL
,	NULL
P.	NULL
Bucher	NULL
,	NULL
M.	NULL
Nabholz	NULL
,	NULL
and	NULL
J.	NULL
Imbert	NULL
.	NULL

1996	NULL
.	NULL

Elf-1	NULL
and	NULL
Stat§	NULL
bind	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
new	NULL
enhancer	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:6829	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
X.-W.	NULL
Liu	NULL
,	NULL
A.	NULL
Wynshaw-Boris	NULL
,	NULL
L.	NULL
A.	NULL
Rosenthal	NULL
,	NULL
K.	NULL
Imada	NULL
,	NULL
D.	NULL
S.	NULL
Finbloom	NULL
,	NULL
L.	NULL
Hennighausen	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
indirect	NULL
effect	NULL
of	NULL
StatSa	NULL
in	NULL
IL-2-induced	NULL
proliferation	NULL
:	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
StatSa	NULL
in	NULL
IL-2-mediated	NULL
IL-2	NULL
receptor	NULL
@	NULL
chain	NULL
induction	NULL
.	NULL

Immunity	NULL
7:691	NULL
.	NULL

Korner	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
and	NULL
P.	NULL
Debre	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
human	NULL
thymocytes	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

181:80	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Cargemont	NULL
,	NULL
V.	NULL
Ferreira	NULL
,	NULL
N.	NULL
Tarantino	NULL
,	NULL
P.	NULL
Debre	NULL
,	NULL
M.	NULL
Raphael	NULL
,	NULL
and	NULL
M.	NULL
Korner	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
Rel-A	NULL
and	NULL
c-Rel	NULL
protein	NULL
complexes	NULL
are	NULL
differentially	NULL
distributed	NULL
within	NULL
human	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2585	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

AP-1	NULL
transcription	NULL
activity	NULL
requires	NULL
both	NULL
T-cell	NULL
receptor-mediated	NULL
and	NULL
costimulatory	NULL
signals	NULL
in	NULL
primary	NULL
T-lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4370	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T-lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Werlen	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
Y.	NULL
Xia	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1998	NULL
.	NULL

Calcineurin	NULL
preferentially	NULL
synergizes	NULL
with	NULL
PKC-theta	NULL
to	NULL
activate	NULL
JNK	NULL
and	NULL
IL-2	NULL
promoter	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:3101	NULL
.	NULL

Brennan	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
W.	NULL
Babbage	NULL
,	NULL
B.	NULL
M.	NULL
T.	NULL
Burgering	NULL
,	NULL
B.	NULL
Groner	NULL
,	NULL
K.	NULL
Reif	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1997	NULL
.	NULL

Phosphatidylinositol	NULL
3-kinase	NULL
couples	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
to	NULL
the	NULL
cell	NULL
cycle	NULL
regulator	NULL
E2F	NULL
.	NULL

Immunity	NULL
7:679	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

Karnitz	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
L.	NULL
A.	NULL
Burns	NULL
,	NULL
S.	NULL
L.	NULL
Sutor	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Abraham	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-2	NULL
triggers	NULL
a	NULL
novel	NULL
Phosphatidylinositol	NULL
3-kinase-dependent	NULL
MEK	NULL
activation	NULL
pathway	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3049	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
Cohen	NULL
.	NULL

1998	NULL
.	NULL

Mechanism	NULL
of	NULL
activation	NULL
and	NULL
function	NULL
of	NULL
protein	NULL
kinase	NULL
B.	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Gen.	NULL
Dev	NULL
.	NULL

8:55	NULL
.	NULL

Downward	NULL
,	NULL
J	NULL
.	NULL

1998	NULL
.	NULL

Mechanisms	NULL
and	NULL
consequences	NULL
of	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
B/Akt	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

10:262	NULL
.	NULL

Abmed	NULL
,	NULL
N.	NULL
H.	NULL
,	NULL
H.	NULL
L.	NULL
Grimes	NULL
,	NULL
A.	NULL
Bellacosa	NULL
,	NULL
T.	NULL
O.	NULL
Chan	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Tsichlis	NULL
.	NULL

1997	NULL
.	NULL

Transduction	NULL
of	NULL
interleukin-2	NULL
antiapoptotic	NULL
and	NULL
proliferative	NULL
signals	NULL
via	NULL
Akt	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:3627	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
Z.-J	NULL
.	NULL

Liu	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthubn	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
266:1045	NULL
.	NULL

Russel	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL-2R	NULL
$	NULL
and	NULL
-y	NULL
,	NULL
chains	NULL
with	NULL
Jak1	NULL
and	NULL
Jak3	NULL
:	NULL
implications	NULL
for	NULL
XSCID	NULL
and	NULL
XCID	NULL
.	NULL

Science	NULL
266:1042	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

3315	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
Miura	NULL
,	NULL
K.	NULL
S.	NULL
Lai	NULL
,	NULL
C.	NULL
Cwik	NULL
,	NULL
E.	NULL
T.	NULL
Liu	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thie	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
signaling	NULL
by	NULL
interleukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Nature	NULL
370:153	NULL
.	NULL

Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
T.	NULL
Miyazaki	NULL
,	NULL
J.	NULL
N.	NULL
Thle	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1995	NULL
.	NULL

Critical	NULL
role	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
y-chain-associated	NULL
Jak3	NULL
in	NULL
the	NULL
TL-2-induced	NULL
c-fos	NULL
and	NULL
c-myc	NULL
,	NULL
but	NULL
not	NULL
bel-2	NULL
,	NULL
gene	NULL
induction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8724	NULL
.	NULL

Zamorano	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Y.	NULL
Wang	NULL
,	NULL
R.	NULL
Wang	NULL
,	NULL
Y.	NULL
Shi	NULL
,	NULL
G.	NULL
D.	NULL
Longmore	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Keegan	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
growth	NULL
by	NULL
IL-2	NULL
:	NULL
role	NULL
of	NULL
STATS	NULL
in	NULL
protection	NULL
from	NULL
apoptosis	NULL
but	NULL
not	NULL
in	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3502	NULL
.	NULL

Goldsmith	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Y.	NULL
Lai	NULL
,	NULL
W.	NULL
Xu	NULL
,	NULL
M.	NULL
C.	NULL
Amaral	NULL
,	NULL
E.	NULL
S.	NULL
Kuczek	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

Parent	NULL
,	NULL
G.	NULL
B	NULL
.	NULL

Mills	NULL
,	NULL
K.	NULL
L.	NULL
Tarr	NULL
,	NULL
G.	NULL
D.	NULL
Longmore	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1995	NULL
.	NULL

Growth	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
requires	NULL
cytoplasmic	NULL
tyrosines	NULL
of	NULL
the	NULL
B	NULL
chain	NULL
and	NULL
non-tyrosine	NULL
residues	NULL
of	NULL
the	NULL
y	NULL
,	NULL
,	NULL
chain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
21729	NULL
.	NULL

Liu	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
S.	NULL
L.	NULL
Gaffen	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Goldsmith	NULL
.	NULL

1998	NULL
.	NULL

JAK/STAT	NULL
signaling	NULL
by	NULL
cytokine	NULL
receptors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10:271	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

